# Dyne Therapeutics, Inc.: Form SC 13D/A, filed Feb 10, 2023

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: SC 13D/A
- Filed: 2023-02-10
- Accepted by EDGAR: Feb 10, 2023, 16:31 ET
- Period: not reported
- Accession: 0001193125-23-032691
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000119312523032691/d403677dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000119312523032691/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000119312523032691/d403677dsc13da.htm

Filed Feb 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-032691. Last ingested by Listed: Nov 14, 2026, 19:07 ET. No prices; not investment advice.
